|
Professional Experience
|
TEACHING
• Coordinator of the Hematology course for medical students, Sackler Faculty of Medicine at Tel Aviv University, Israel, 2009-2011
• Pediatric Hematology oncology lectures for medical students and nurses,
1996 – Present.
• Tutor in charge of medical students, 1991-1992
PROJECTS
· Director of the computerized program of the inpatient and outpatient computerized medical record
· Establishment of computerized chemotherapy protocols and patient’s database, 1999 – 2014.
CLINICAL TRIALS EXPERIENCE
• Principle investigator of the High Risk Neuroblastoma 1.7 ESIOP protocol, Sheba medical center, 2002 – present.
• Principle investigator of the “Phase I/II, 2-part, Multi Center, Single arm, Open-Label Study, to determine the Safety, Tolerability and Pharmacokinetics of oral Dabrafenib in Children and Adolescent Subjects with Advanced BRAF V-600 Mutation Positive Solid Tumors. 2015-2016
• Principle investigator of the “Single-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects at Risk for a Venous or Arterial Thrombotic Disorder” 2013-2015
· National coordinator of the High Risk Neuroblastoma 1 ESIOP protocol, 2002 – 2005
· Active involvement in several basic research programs including:
• Identification and isolation of cancer stem cells in pediatric malignancies in order to identify targetable markers (2 papers are currently in the processes of submission)
• The role of cannabinoids as anti-cancer drug in pediatric malignancies
Positions
• Deputy Director of the Pediatric Hemato-Oncology and BMT Division
• Head of the Pediatric Hemato-Oncology Day Care Service
• Professional memberships: Israel Medical Association, Israel Society of Pediatric Hematology Oncology, Israel Society of Hematology and Blood Transfusions |